Developing expanded capacity in the Pilbara will never be cheaper and doing so without the need for capital-raising is a no-brainer. Producing 2 million tonnes per year will make PLS an excellent long-term dividend stock.
The hype about climate change will fade, replaced by fear of nuclear war or whatever else Governments and the media will use to scare the population.
When the Chinese complete their 2000km road and rail link between Monano in the heart of the DRC and the west coast of Africa the world's largest lithium resource will become available and Chinese manufacturers will capitalise on it. The good news from Africa will be tempered by wars, disease, famine and corruption. If PLS continues to produce quality product reliably from Australia one would expect it to be worth holding for long-term, passive income.
- Forums
- ASX - By Stock
- PLS
- Ann: Study Delivers 2MTPA Expansion Option - Highly Accretive
Ann: Study Delivers 2MTPA Expansion Option - Highly Accretive, page-108
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.06 |
Change
0.040(1.32%) |
Mkt cap ! $9.210B |
Open | High | Low | Value | Volume |
$3.04 | $3.12 | $3.02 | $47.88M | 15.58M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 321604 | $3.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.07 | 269930 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 98240 | 3.060 |
13 | 82683 | 3.050 |
13 | 75513 | 3.040 |
10 | 29960 | 3.030 |
20 | 88646 | 3.020 |
Price($) | Vol. | No. |
---|---|---|
3.070 | 400 | 1 |
3.080 | 7280 | 2 |
3.090 | 11600 | 2 |
3.100 | 66993 | 13 |
3.110 | 237299 | 9 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
PLS (ASX) Chart |